Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency

Background: Patients with predominantly antibody deficiency (PAD) have lower anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2-dose SARS-CoV-2 vaccination than healthy controls do; however, the anti-spike antibody responses and neutralization fun...

Full description

Bibliographic Details

Published in:	Journal of Allergy and Clinical Immunology: Global
Main Authors:	Anna M. Zhang, MD, Ahmed Elmoursi, MD, MPH, Daniel V. DiGiacomo, MD, MPH, Baijun Zhou, MHS, Megha Tandon, BA, Joseph S. Hong, BS, Nancy J. Yang, BS, Mei-Sing Ong, PhD, Anand S. Dighe, MD, PhD, Cristhian Berrios, MD, Mark C. Poznansky, MD, PhD, Anthony J. Iafrate, MD, PhD, Vivek Naranbhai, PhD, MB, ChB, Alejandro Balazs, PhD, Shiv Pillai, MBBS, PhD, Jocelyn R. Farmer, MD, PhD, Sara Barmettler, MD
Format:	Article
Language:	English
Published:	Elsevier 2024-05-01
Subjects:	Predominantly antibody deficiency SARS-CoV-2 common variable immunodeficiency anti-spike antibody Omicron BA.5 variant neutralization
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772829324000304